Vertex Pharmaceuticals Incorporated (VRTX) Receives Average...


Shares of Vertex Pharmaceuticals Incorporated have been given an average rating of "Buy" by the thirty-one ratings firms that are currently covering the company, Marketbeat.com reports. One analyst has rated the stock with a sell rating, five have issued a hold rating, twenty-three have assigned a buy rating and one has given a strong buy rating to the company.



from Biotech News